Document is current
Any future updates will be listed below
-
Authors
Liu, Lingchen
Zhang, Jia
Wood, Scott
Newell, Felicity
Leonard, Conrad
Koufariotis, Lambros T.
Nones, Katia
Dalley, Andrew J.
Chittoory, Haarika
Bashirzadeh, Farzad
Son, Jung Hwa
Steinfort, Daniel
Williamson, Jonathan P.
Bint, Michael
Pahoff, Carl
Nguyen, Phan T.
Twaddell, Scott
Arnold, David
Grainge, Christopher
Simpson, Peter T.
Fielding, David
Waddell, Nicola
Pearson, John V.
- License Information
-
More Information
Article History
Received: 1 March 2024
Accepted: 11 September 2024
First Online: 30 September 2024
Declarations
:
: The lung cancer samples sequenced in this study were obtained from patients with SCLC. Research was conducted in accordance with the Declaration of Helsinki and the Australian National Statement on Ethical Conduct in Human Research. Human research ethics was approved by the Royal Brisbane and Women’s Hospital human research ethics committee (HREC, HREC/17/QRBW/301) and ratified by the HRECs of QIMR Berghofer (P2404) and the University of Queensland (2018/HE001615). All patients provided written informed consent to participate in research.
: Not applicable.
: John V. Pearson and Nicola Waddell are co-founders of genomiQa. LL and NW were funded by Oxford Nanopore to present work from this study at meetings. The remaining authors declare that there are no competing interests.
